Found: 10
Select item for more details and to access through your institution.
Recombinant probiotic Lactococcus lactis delivering P62 mitigates moderate colitis in mice.
- Published in:
- Frontiers in Microbiology, 2024, p. 01, doi. 10.3389/fmicb.2024.1309160
- By:
- Publication type:
- Article
Lactococcus lactis as an Interleukin Delivery System for Prophylaxis and Treatment of Inflammatory and Autoimmune Diseases.
- Published in:
- Probiotics & Antimicrobial Proteins, 2024, v. 16, n. 2, p. 352, doi. 10.1007/s12602-023-10041-1
- By:
- Publication type:
- Article
Synergistic synbiotic containing fructooligosaccharides and Lactobacillus delbrueckii CIDCA 133 alleviates chemotherapy-induced intestinal mucositis in mice.
- Published in:
- World Journal of Microbiology & Biotechnology, 2023, v. 39, n. 9, p. 1, doi. 10.1007/s11274-023-03679-0
- By:
- Publication type:
- Article
Growth differentiation factor 11 delivered by dairy Lactococcus lactis strains modulates inflammation and prevents mucosal damage in a mice model of intestinal mucositis.
- Published in:
- Frontiers in Microbiology, 2023, p. 01, doi. 10.3389/fmicb.2023.1157544
- By:
- Publication type:
- Article
Evaluation of Probiotic Properties of Novel Brazilian Lactiplantibacillus plantarum Strains.
- Published in:
- Probiotics & Antimicrobial Proteins, 2023, v. 15, n. 1, p. 160, doi. 10.1007/s12602-022-09978-6
- By:
- Publication type:
- Article
Safety Evaluation of Lactobacillus delbrueckii subsp. lactis CIDCA 133: a Health-Promoting Bacteria.
- Published in:
- Probiotics & Antimicrobial Proteins, 2022, v. 14, n. 5, p. 816, doi. 10.1007/s12602-021-09826-z
- By:
- Publication type:
- Article
Paraprobiotics and Postbiotics of Lactobacillus delbrueckii CIDCA 133 Mitigate 5-FU-Induced Intestinal Inflammation.
- Published in:
- Microorganisms, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/microorganisms10071418
- By:
- Publication type:
- Article
Lactobacillus delbrueckii CIDCA 133 Ameliorates Chemotherapy-Induced Mucositis by Modulating Epithelial Barrier and TLR2/4/Myd88/NF-κB Signaling Pathway.
- Published in:
- Frontiers in Microbiology, 2022, v. 13, p. 1, doi. 10.3389/fmicb.2022.858036
- By:
- Publication type:
- Article
Intake of Lactobacillus delbrueckii (pExu: hsp65) Prevents the Inflammation and the Disorganization of the Intestinal Mucosa in a Mouse Model of Mucositis.
- Published in:
- Microorganisms, 2021, v. 9, n. 1, p. 107, doi. 10.3390/microorganisms9010107
- By:
- Publication type:
- Article
Probiotics, Prebiotics, Synbiotics, and Paraprobiotics as a Therapeutic Alternative for Intestinal Mucositis.
- Published in:
- Frontiers in Microbiology, 2020, v. 11, p. N.PAG, doi. 10.3389/fmicb.2020.544490
- By:
- Publication type:
- Article